Skip to content
Sign in
Artwork for Pearls and Prep
EducationHealth & FitnessMental HealthMedicine

Pearls and Prep

NP Z

******* There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Be the second on Patreon:

https://www.patreon.com/c/PearlsandPrep

Pearls and Prep: Psychiatric Case Studies is the go-to podcast for psychiatric nurse practitioner students, psych residents, clinicians, and anyone fascinated by the human mind. Whether you’re prepping for boards, sharpening your diagnostic skills, or just curious about what psychiatry looks like behind the scenes, this show delivers clinical gold in every episode.

🎯 What You’ll Learn:
Each episode walks you through real-world psychiatric case studies — from initial chart review to final treatment plan — using a structured, digestible, and evidence-based approach. You'll get:

🩺 Psychiatric differential diagnosis deep-dives

💊 Psychopharmacology breakdowns with receptor targets, MOA, half-lives, and pearls for side effect management

📖 DSM-5-TR criteria reviews, clearly explained and clinically applied

⚖️ Rule-outs and red flags, with rationale

🧠 Cognitive frameworks for organizing your clinical thinking

📚 Citations and recent research from PubMed and clinical trials

😄 Engaging, story-based cases with humor, humility, and real-life complexity

Each case is crafted to model what clinical decision-making looks like in the real world: nuanced, flexible, and guided by both science and soul. You’ll hear about everything from bipolar depression and PTSD to OCD, ADHD, panic disorder, substance use, and treatment-resistant depression — all through the lens of compassionate, competent care.

🧠 Why This Podcast?
There are lots of psych podcasts, but Pearls and Prep is different. It’s not just lectures or interviews — it’s clinical rehearsal meets storytelling. Each episode is a teaching round in audio form, designed to help you think like a psych NP or psychiatrist. The cases are quirky, realistic, and designed to leave you with:

💡 High-yield memory hooks

📊 Clinical decision-making tools

📌 Ready-to-use documentation phrases

🧾 Smart screening questions

🧪 Lab interpretation tips for psychiatry

⚕️ First-line treatment recommendations based on guidelines and nuance

Perfect for students prepping for ANCC or AANP boards, for seasoned clinicians wanting to refresh their diagnostic edge, or for preceptors looking to sharpen their teaching game.

This podcast uses the following third-party services for analysis:

Podcorn - https://podcorn.com/privacy

Play
Open in
  • 21 episodes
  • Avg 23 min
  • English

Support the show

Goes straight to the publisher. podnod takes nothing.

Episodes 21

NewestOldestLongest
All20Unplayed20In progress0Played0
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • S1 · E33
    Tuesday · 21 min

    Schizoid or Schizotypal? The Clinical Clues That Give It Away

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep Schizoid or Schizotypal? They Look Alike—Until You Ask WHY Schizoid and schizotypal personality disorder sound alike—and both patients may appear socially isolated, detached, or eccentric—but the reason WHY they withdraw can be completely different. In this episode of Pearls and Prep, NPZ breaks down schizoid vs schizotypal personality disorder using practical outpatient clues: what these patients may actually say in your office, why they avoid relationships, how their social histories differ, and what to listen for when exploring suspiciousness, ideas of reference, magical thinking, unusual beliefs, and restricted affect. We also tackle the differentials that can trip clinicians up: schizophrenia and psychosis, autism spectrum disorder, depression, social anxiety, and avoidant personality disorder. The big pearl: don't just notice that your patient is isolated—figure out WHY they're isolated. That distinction can completely change your diagnostic formulation. 🎧 Your preceptor in your pocket: practical psychiatric pearls that prep you to practice. 33 Schizoid or Schizotypal? The Clinical Clues That Give It Away Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
  • S1 · E32
    September 15 · 24 min

    Why I Have a Love-Hate Relationship with Latuda

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep Why I Have a Love-Hate Relationship with Latuda Latuda (lurasidone) is one of the most unique medications in psychiatry—but it's also one of the easiest to misunderstand. In this episode of Pearls & Prep, we break down exactly when Latuda shines, where it falls short, and how experienced clinicians think through prescribing it in real practice. You'll learn: • Why Latuda is FDA-approved for bipolar I depression and schizophrenia • Why it treats depression but isn't your best option for mania prevention • How Latuda compares with Seroquel, Abilify, Lamictal, lithium, and Symbyax • The importance of treating both poles of bipolar disorder—not just today's symptoms • The famous 350-calorie food requirement and why it matters clinically • Why Latuda is considered one of the more weight-neutral antipsychotics • Common adverse effects including akathisia, nausea, and movement disorders • Practical prescribing pearls you'll actually remember during patient care Whether you're a PMHNP student, psychiatric NP, psychiatry resident, physician assistant, medical student, or practicing clinician, this episode focuses on the clinical reasoning behind medication selection—not just memorizing facts. If you're preparing for boards or simply want to become more confident prescribing psychiatric medications, this episode is packed with practical psychopharmacology pearls. 32 Why I Have a Love-Hate Relationship with Latuda Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
  • S1 · E31
    September 8 · 23 min

    Inside the Ring 🥊: Effexor or Cymbalta? Here’s the Real Difference

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep We’re diving deep into the showdown of the century: Cymbalta vs. Effexor! This isn’t just another med comparison; we’re talking about the nitty-gritty of which one might actually be a better fit for your patients based on their unique circumstances. Just like the classic debates over LeBron vs. MJ, or Yankees vs. Red Sox, it’s all about context here. If you've got a patient battling chronic pain, Cymbalta is often the MVP, but throw in social anxiety and Effexor might steal the spotlight. We’ll break down the ins and outs of these meds, so you can have the knowledge to back up your prescribing game and make your patients feel empowered. Trust me, this is the kind of talk that'll level up your clinical skills! 31 Inside the Ring 🥊: Effexor or Cymbalta? Here’s the Real Difference Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Diving into the juicy details of Cymbalta versus Effexor, we tackle the age-old debate of which med comes out on top. It’s not just about who wears the crown; it’s about the context, baby! Our chat kicks off with a rundown of each medication’s strengths. If your patient is wrestling with chronic pain, Cymbalta is like a heavyweight champ, knocking out discomfort in conditions like fibromyalgia and diabetic neuropathy. But wait—if social anxiety or panic is more their jam, Effexor might take the lead with its FDA approval for those specific issues. Just like comparing LeBron to MJ, it’s all about the situation at hand! We explore the nitty-gritty of psychopharmacology, empowering folks to make informed decisions when prescribing. As we roll along, we get into the weeds of how these meds actually work. The conversation takes a turn towards the complexities of FDA approvals and manufacturer motivations. It turns out, Cymbalta was all about pain trials, while Effexor was strutting its stuff in the anxiety arena. But here’s the kicker: just because Cymbalta isn’t FDA-approved for social anxiety doesn’t mean it’s a slouch in that department. We’re here to remind you that real-life practice doesn’t always align with textbook rules. Every patient is a unique puzzle, and understanding their pain versus anxiety levels can make all the difference in choosing the right med. Wrapping it up, we emphasize the importance of patient context and the subtleties that can sway a prescribing decision. We touch on the potential for side effects, protein binding quirks, and the unpredictable nature of drug interactions. It’s a rollercoaster of insights that leaves us with a reminder: there’s no one-size-fits-all answer—just like in life, it’s about finding what fits best for each individual. Tune in for a smart and sassy breakdown of the meds that can change lives! Takeaways: Cymbalta is a solid choice for patients with chronic pain, like fibromyalgia, while Effexor shines brighter for anxiety disorders. Understanding the context of a patient's condition is crucial when choosing between Cymbalta and Effexor; it's not one-size-fits-all. Both Cymbalta and Effexor have unique properties that make them effective, but their indications can vary based on individual patient needs. Medication interactions are a big deal; if your patient is on multiple drugs, keeping an eye on protein binding is super important for safety. Companies mentioned in this episode: Cymbalta Effexor This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
    • Chapters
  • S1 · E34
    September 4 · 22 min

    How to Interview Psychiatric Patients With Confidence: 4 Skills Every New PMHNP Needs

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep Want to feel more confident interviewing psychiatric patients? In this episode of Pearls and Prep, NPZ shares 4 psychiatric interview skills every new PMHNP needs to conduct smoother, more organized, and more human psychiatric evaluations. Learn how to use a structured psychiatric intake, build genuine therapeutic rapport, recognize important clinical clues, ask better follow-up questions, and develop a repeatable system that keeps your evaluation on track. You’ll also learn two memorable interviewing techniques: the “life raft” approach for helping patients feel genuinely heard and the “squeeze the orange” technique for recognizing and exploring the valuable diagnostic clues patients drop during their stories. Whether you're a PMHNP student, new psychiatric nurse practitioner, or new mental health provider, these practical psychiatric evaluation tips will help you ask better questions, improve your clinical interviewing skills, and walk into your next patient encounter with more confidence. 🎧 Pearls and Prep: Your preceptor in your pocket. Topics: psychiatric interview skills, psychiatric evaluation, PMHNP, PMHNP student, psychiatric assessment, mental health assessment, psychiatric intake, new grad PMHNP, clinical interviewing, therapeutic rapport 34 How to Interview Psychiatric Patients With Confidence: 4 Skills Every New PMHNP Needs Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
  • S1 · E30
    September 1 · 30 min

    Why LAIs Are the Real MVPs in Psychiatry

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep Today, we're diving into the world of long-acting injectable medications—LAIs for short. These bad boys are a game-changer in psychiatry, offering some serious perks. We’ll chat about how they bypass the messy first-pass metabolism of oral meds, making them more reliable and predictable for patients. I mean, who doesn’t want fewer side effects and more consistent plasma levels? Plus, we’ll explore how LAIs help keep patients engaged with their healthcare, which is a win-win for everyone involved. So grab a comfy seat and let’s get into the nitty-gritty of why LAIs might just be the secret sauce to better patient outcomes! 30 Why LAIs Are the Real MVPs in Psychiatry Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink We dove deep into the world of long-acting injectables (LAIs) today, and let me tell you, it was a wild ride! Think of LAIs as the cool cousins of your everyday oral meds. Instead of popping pills every day like a game of medication whack-a-mole, these bad boys are injected and can last for weeks—talk about convenience! We chatted about how LAIs can bypass the dreaded first-pass metabolism (yawn, I know) and go straight into the bloodstream, making them more reliable. This means fewer side effects and a smoother ride for our patients. Plus, we covered the magic of “flip-flop pharmacokinetics”—no, that’s not a new dance move! It’s all about how LAIs slowly release their medication, giving patients a steady dose without those dramatic peaks and troughs that oral meds can cause. So, if you’ve got patients who struggle with taking their meds regularly, LAIs might just be the superhero they need. Takeaways: Long acting injectables (LAIs) offer a reliable way to bypass hepatic metabolism for better drug absorption. When prescribing LAIs, you reduce the variability of medication effects across different patients, which can simplify treatment. LAIs can help create regular healthcare interactions, leading to better overall management of patient health and adherence to other medications. Understanding the pharmacokinetics of LAIs is crucial, as they provide a steadier plasma level compared to oral meds. Adherence is a huge problem in medication management, and LAIs can significantly improve patient compliance. Using LAIs proactively can prevent relapses rather than reactively responding after issues arise. Companies mentioned in this episode: Zyprexa Abilify Lexapro Prozac Paxil Latuda Invega This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
    • Chapters
  • S1 · E29
    August 25 · 16 min

    Drug Tests Aren’t Always Right—Here’s Where Things Go Wrong

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Be the second on Patreon: 👉 https://www.patreon.com/PearlsandPrep Today, we're diving into the wild world of false positive drug screens and how they can throw a wrench in a patient's treatment plan. We’ll share Jimmy's story, a (mock patient) guy whose life took a serious detour because of miscommunication and medication mishaps. He was on a roll—getting his life together, taking care of his daughter, and then boom! A positive drug screen for benzodiazepines, even though he wasn’t taking any. Turns out, the meds he was prescribed can cause these false positives, and nobody connected those dots. We’ll unpack this mess and chat about how crucial it is to communicate in the medical field, so we can avoid putting patients in hot water when they’re just trying to do their best. Stick around for some pearls of wisdom that might just help keep our patients safe and sound! 29 Drug Tests Aren’t Always Right—Here’s Where Things Go Wrong Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Let’s dive into the messy world of drug screens, shall we? We kick things off with our buddy Jimmy, a 34-year-old insurance salesman who’s been keeping his life in check with some serious help from his opioid treatment program. He’s been doing great—negative drug tests for a whole year, even got to take home his meds like a champ! But then, bam! His psychiatrist throws some new meds into the mix without a heads-up to his treatment team, and suddenly Jimmy’s life spirals into chaos. We break down how a couple of common prescriptions can mess with drug tests, leading to false positives that can ruin lives. Our convo flows from the nitty-gritty of communication breakdowns in healthcare to the real-life implications for patients like Jimmy. Spoiler alert: it’s a wild ride that shows how easy it is to misinterpret a drug test and the devastating consequences that can follow. Buckle up! Takeaways: In this episode, we dived deep into how false positive drug screens can really mess with treatment plans, especially in the world of psychiatry. We shared a wild case about Jimmy, whose meds led to a false positive for benzos, causing him to lose take-home privileges – talk about a bummer! Communication is key, folks! Jimmy's story shows how a lack of info between doctors can lead to major misunderstandings and hurt patients' progress. Turns out, meds like Zoloft and Trazodone can trigger false positives for benzodiazepines, which is just one reason we need to be on our game with prescribing. We need to advocate for confirmatory testing – don’t let false positives ruin your life or your treatment plan, people! Overall, the episode was all about ensuring we understand the meds we prescribe and how they can impact our patients' lives in unexpected ways. Companies mentioned in this episode: Sertraline Trazodone Quetiapine Seroquel Dairy Queen Abilify Effexor Wellbutrin This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
  • S1 · E28
    August 11 · 28 min

    ADHD or Bipolar? The Questions That Actually Reveal the Truth

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Be the second on Patreon: 👉 https://www.patreon.com/PearlsandPrep We’re diving into a juicy case study today, featuring our mock patient, Debbie, and her whirlwind of symptoms that might have you guessing whether she’s dealing with ADHD or bipolar disorder. The big takeaway? These two can look a whole lot alike, and getting it wrong can lead to some serious consequences, like triggering a manic episode when all you wanted to do was help. We’ll chat about how important it is to ask the right questions and dig deep into a patient’s history to figure out what’s really going on. Plus, we’ll share some pearls of wisdom on how to tease apart these diagnoses, because not everything in the mental health world comes neatly packaged. So, buckle up as we sort through Debbie's story and uncover what it all means! 28 ADHD or Bipolar? The Questions That Actually Reveal the Truth Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Debbie shows up to the clinic with what looks like a classic case of indecisiveness mixed with a sprinkle of chaos. She’s got a history that sounds like a sitcom episode—projects started and abandoned like they were hot potatoes. Whether she’s just got a wild case of ADHD or if there’s something more sinister, like bipolar lurking behind her cheerful facade, is the million-dollar question. As we peel back the layers of her story, we learn about her impulsive spending habits, job losses, and some familial ties to mental health issues that make us raise an eyebrow. The show dives deep into the importance of distinguishing between ADHD and bipolar disorder, emphasizing that missteps in diagnosis can lead to significant treatment blunders. If we slap an Adderall label on her without figuring out the bipolar puzzle, we might just send her spiraling into a manic episode. It's a wild ride of clinical insights and personal anecdotes, all while we figure out the nuances of mental health diagnoses that can be as tricky as untangling earbuds. Takeaways: Understanding the overlap between ADHD and bipolar disorder is crucial for accurate diagnosis and treatment. Debbie's impulsive spending and project abandonment raise concerns about potential manic episodes. Sleep patterns can be a key indicator in differentiating between ADHD and bipolar disorder symptoms. Getting collateral history from family or friends can help clarify a patient's condition and behavior patterns. Exploring a patient's work history can reveal patterns that indicate either ADHD or bipolarity. Recognizing the timing of symptom onset is essential in distinguishing between ADHD and bipolar disorder. This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
    • Chapters
  • S1 · E33
    August 10 · 22 min

    The Insomnia Trap: Stop Treating Every Sleepless Psychiatric Patient the Same

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep What do you do when your psychiatric patient is depressed, anxious, traumatized—or struggling with ADHD—and also tells you they can’t sleep? This is one of the most common clinical dilemmas new psychiatric nurse practitioners and PMHNP students encounter. Your patient needs treatment for depression or anxiety, but you know an SSRI or SNRI may initially feel activating. They’re already exhausted. They want to sleep tonight. So do you add trazodone? Choose mirtazapine? Try low-dose doxepin or ramelteon? Start the SSRI and wait? Or are you treating the wrong problem entirely? In this episode of Pearls and Prep, NPZ breaks down a more methodical way to think about insomnia in psychiatric practice: before treating sleeplessness, figure out what is actually keeping the patient awake. Insomnia is incredibly transdiagnostic. A patient with major depressive disorder may lie awake ruminating about the past, guilt, worthlessness, or perceived failures. A patient with an anxiety disorder may be forecasting everything that could go wrong tomorrow. PTSD may produce hyperarousal, hypervigilance, nightmares, and a nervous system that never seems to feel safe enough to shut down. ADHD can create a different nighttime experience altogether—unfinished tasks, forgotten emails, executive dysfunction, and the feeling that the brain simply won’t turn off. Those differences matter because they can change your treatment strategy. We discuss why successfully treating the underlying psychiatric disorder with an SSRI or SNRI can sometimes improve sleep without the medication itself being sedating. We also explore situations where mirtazapine (Remeron) may give you multiple therapeutic advantages at once—particularly when depression or anxiety occurs alongside insomnia and poor appetite—and why duloxetine (Cymbalta) may deserve consideration when pain is one of the major reasons your patient cannot sleep. Then we tackle the harder question: what if treating the underlying condition isn’t enough? We walk through CBT-I and why cognitive behavioral therapy for insomnia needs to remain part of the conversation, while also acknowledging the real-world barriers psychiatric clinicians encounter when patients cannot access it, cannot afford it, don’t have time for it, or simply want relief now. From there, we examine the medication toolbox clinicians commonly encounter, including mirtazapine, trazodone, low-dose doxepin, ramelteon, melatonin, Z-drugs, and newer insomnia treatments. More importantly, we focus on the clinical reasoning behind reaching—or not reaching—for another medication. Because “this drug is sedating” is not a diagnosis. We also zoom out to the differential diagnosis. Could nighttime racing thoughts actually represent bipolar disorder? Could the patient have obstructive sleep apnea, restless legs, excessive caffeine intake, medication-induced activation, hyperthyroidism, pain, PTSD-related hyperarousal, or another contributor that you’ll completely miss if you simply prescribe something to knock them out? This episode is designed for PMHNP students, psychiatric nurse practitioners, new psychiatric prescribers, and clinicians who want to become more deliberate about treating insomnia alongside depression, anxiety, PTSD, ADHD, and other psychiatric conditions. The goal isn’t to memorize another list of sleep medications. It’s to become the clinician who can answer the more important question: Why can’t this particular patient sleep—and what treatment actually matches that reason? 🎧 Pearls and Prep — unforgettable psychiatry pearls for PMHNP students and psychiatric clinicians who want to understand the WHY behind their prescribing. Want to go deeper? Join Pearls and Prep on Patreon for psychiatric visuals, psychopharmacology deep dives, clinical reasoning resources, and Mafia Pearl™, where I become your mock patient so you can practice interviewing, diagnosis, and treatment decisions before they matter in the real clinical encounter. 33 The Insomnia Trap: Stop Treating Every Sleepless Psychiatric Patient the Same Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
  • S1 · E33
    August 8 · 16 min

    Effexor Explained: Why, When & Who?

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep Effexor Explained: Why, When & Who? Effexor (venlafaxine) is more than just another antidepressant—and knowing when and why to choose it can make you a much more thoughtful psychiatric prescriber. In this episode of Pearls & Prep, we break down Effexor and venlafaxine from a practical psychopharmacology perspective. Where does this SNRI fit after an inadequate response to SSRIs like Lexapro or Prozac? Which patients might benefit most? And why can Effexor be incredibly useful while also having one of the most notorious antidepressant discontinuation syndromes? We’ll explore Effexor for major depressive disorder (MDD), generalized anxiety disorder (GAD), panic disorder, and social anxiety disorder, along with some of its useful benefits outside traditional psychiatric symptoms—including migraine prevention and menopausal vasomotor symptoms such as hot flashes. We also dig into what makes venlafaxine pharmacologically interesting. At lower doses, Effexor behaves predominantly as a serotonergic antidepressant, while increasing doses bring greater norepinephrine reuptake inhibition into the picture. Understanding this dose-dependent mechanism can help psychiatric nurse practitioners think more strategically about residual symptoms such as low energy, fatigue, and difficulty concentrating. But Effexor has tradeoffs. We discuss its short half-life, missed doses, brain zaps, nausea, flu-like symptoms, irritability, and why medication adherence becomes especially important with venlafaxine. We also explore when Effexor may be a poor choice for a patient who already struggles to take medications consistently. Finally, we tackle a commonly overlooked piece of psychopharmacology: CYP450 metabolism. Learn why CYP2D6 matters with venlafaxine, how medications such as Prozac and Paxil can complicate the picture, and why prescribers need to think about not only what enzymes a psychiatric medication inhibits—but also which enzymes are responsible for metabolizing the medication itself. If you’re a PMHNP student, psychiatric nurse practitioner, psychiatry resident, or clinician trying to understand antidepressants beyond memorizing drug charts, this episode is designed to help you understand the WHY behind Effexor. Because good psychopharmacology isn’t eeny, meeny, miny, moe. The goal is to understand the differences between medications well enough to match the medication to the patient sitting in front of you. Topics include: Effexor, venlafaxine, SNRI pharmacology, antidepressants, depression treatment, anxiety treatment, panic attacks, panic disorder, GAD, social anxiety disorder, Effexor withdrawal, venlafaxine discontinuation syndrome, brain zaps, CYP2D6, psychotropic drug interactions, antidepressant switching, migraines, menopausal hot flashes, psychopharmacology, PMHNP education, psychiatric medications, and psychiatric prescribing. 33 Effexor Explained: Why, When & Who? Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
  • S1 · E27
    August 4 · 28 min

    Are We Missing One of Psychiatry’s Easiest Wins? (Metformin)

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Be the second on Patreon: 👉 https://www.patreon.com/PearlsandPrep We're diving deep into the world of Metformin today, folks! This little gem is often overlooked, but it’s a total game-changer for managing weight gain from antipsychotics. Seriously, we’re talking about a cheap, effective med that could save our patients from a whole lot of metabolic trouble. It’s wild that only about 2-3% of folks who could benefit from it are actually getting prescribed Metformin—talk about a missed opportunity! We're here to shake things up and help you feel more comfortable adding this powerhouse to your toolbox, because keeping our patients healthy and happy is what it’s all about. So buckle up, because we're about to unpack why this underdog deserves a spot in your practice! 27 Are We Missing One of Psychiatry’s Easiest Wins? (Metformin) Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Takeaways: Metformin is a total game changer for preventing weight gain with psych meds, seriously. A staggering 2 to 3% of folks who need Metformin for weight issues actually get it prescribed. Weight gain from antipsychotics is the number one reason for patients ditching their meds; we gotta fix this. We should be proactive with Metformin, not reactive; waiting is just bad news, fam. Understanding how Metformin works and its benefits is crucial for our practice, no doubt about it. Don't underestimate the power of a simple, cheap med like Metformin; it can save lives. Companies mentioned in this episode: Metformin Zyprexa Seroquel Cymbalta Prozac Zoloft Geodon Abilify Latuda Risperdal This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
    • Chapters
  • S1 · E33
    August 3 · 24 min

    Prozac vs Zoloft: They Look the Same... But They're Not at All

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep Prozac vs Zoloft: They Look the Same... But They're Not at All Prozac (fluoxetine) and Zoloft (sertraline) are both SSRIs, both first-line treatments for depression, and both commonly prescribed for anxiety disorders—but they are far from interchangeable. In this episode of Pearls & Prep, we go beyond the textbook to explore the practical clinical reasoning behind choosing Prozac vs Zoloft. You'll learn why one patient may thrive on Prozac while another is a much better fit for Zoloft—and how experienced psychiatric clinicians think through that decision. We'll cover: • Why Prozac's long half-life is both one of its greatest strengths and one of its biggest drawbacks • Why Prozac is often easier to discontinue—but much harder to wash out when side effects occur • The famous "little old lady getting off the bus" analogy for remembering fluoxetine's long half-life • Why Zoloft is often the better choice in patients taking multiple medications because it has fewer clinically significant drug interactions • Understanding CYP2D6 inhibition and why Prozac can increase levels of medications like Abilify, risperidone, tamoxifen, and others • Why sertraline is generally considered more "flexible" in medically complex patients • FDA approvals that actually matter in practice, including PTSD, PMDD, social anxiety disorder, panic disorder, OCD, bulimia nervosa, and depression • Why Prozac remains the only FDA-approved SSRI for bulimia nervosa • How Prozac becomes Symbyax when combined with olanzapine for bipolar I depression—and why that combination can be incredibly effective despite its metabolic tradeoffs • Which medication is generally preferred during breastfeeding • Differences in activation, insomnia, nausea, diarrhea, withdrawal symptoms, sexual dysfunction, and common adverse effects • Why your own prescribing experiences can create bias—and how evidence-based medicine helps keep us honest This episode isn't about memorizing medication facts. It's about learning how to think like a psychiatric prescriber. By the end, you'll understand not only the pharmacology behind fluoxetine and sertraline, but also the clinical reasoning that helps you confidently choose the right SSRI for the right patient. Whether you're a PMHNP student, psychiatric nurse practitioner, psychiatry resident, physician assistant, medical student, or practicing mental health clinician, this episode will give you practical psychopharmacology pearls you can immediately apply in clinic and remember long after boards are over. 📚 Want even more sticky psychiatry? Join the Pearls & Prep Patreon for: Premium visual psychopharmacology graphics Board Bombs study resources Weekly Pearl Drops Full psychiatry learning library Live mock patient simulations Personalized written feedback through the Mafia Pearl mentorship 👉 patreon.com/pearlsandprep 33 Prozac vs Zoloft: They Look the Same... But They're Not at All Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
  • S1 · E32
    July 31 · 23 min

    Would You Diagnose PTSD, Depression, or Adjustment Disorder? One Patient. Three Diagnoses. Key Clinical Pearls You Should Know That Separate Them.

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep Episode Description One patient. Three possible DSM-5 diagnoses. Only one is correct. In this episode of Pearls & Prep, NPZ walks you through one of the most realistic—and challenging—psychiatric differential diagnoses you'll encounter in clinical practice. At first glance, this patient appears to meet criteria for PTSD, Major Depressive Disorder (MDD), and Adjustment Disorder simultaneously. But as you'll discover, great psychiatric diagnosis isn't about memorizing DSM criteria—it's about asking the right questions. Using a real-world clinical case, we'll slow down the diagnostic process and examine how experienced psychiatric clinicians separate normal grief, adjustment disorder, major depression, and PTSD without rushing to label every emotional response as mental illness. In this episode you'll learn: • How to distinguish Adjustment Disorder vs Major Depressive Disorder • When grief is normal—and when it becomes something more • What actually qualifies as a Criterion A trauma for PTSD • Why simply experiencing trauma does not automatically equal PTSD • The interview questions that reveal the diagnosis hiding underneath the symptoms • How guilt differs in depression versus trauma-related reactions • The difference between circumscribed distress and global psychological impairment • Why anhedonia and worthlessness are often more diagnostically useful than sadness alone • Common mistakes new psychiatric providers make when diagnosing trauma and depression • Practical interviewing pearls you can immediately use during psychiatric evaluations Whether you're a PMHNP student, psychiatry resident, practicing clinician, or preparing for board exams, this episode will sharpen your diagnostic reasoning and help you avoid one of the most common—and most important—mistakes in psychiatric practice: treating the wrong disorder because multiple diagnoses appear to fit. Remember: the quality of your diagnosis depends on the quality of your questions. Every medication decision, treatment plan, and patient outcome begins with getting the diagnosis right. 🎩 Want access to the full clinical vault? Become a Boss Pearl on Patreon and unlock exclusive premium episodes, psychopharmacology deep dives, Board Bombs, interview pearls, downloadable clinical resources, and much more. Looking for personalized coaching? Join the MAFIA Pearl™ tier for live psychiatric interview simulations, individualized written feedback, diagnostic coaching, medication selection guidance, and direct mentorship designed to accelerate your clinical confidence. Practice psychiatry before it matters. 32 Would You Diagnose PTSD, Depression, or Adjustment Disorder? One Patient. Three Diagnoses. Key Clinical Pearls You Should Know That Separate Them. Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
  • S1 · E32
    July 30 · 33 min

    How I Choose Antipsychotics in Real Clinical Practice: 4 Pearls That Will Transform Your Bipolar Prescribing

    How I Choose Antipsychotics in Real Clinical Practice: 4 Pearls That Will Transform Your Bipolar Prescribing How do experienced psychiatric providers actually choose between Seroquel, Abilify, Latuda, Vraylar, Risperdal, Zyprexa, and Geodon? In this episode, I share the exact clinical framework I use every day when prescribing second-generation antipsychotics (SGAs) for bipolar disorder. Rather than memorizing medication lists, you'll learn four practical prescribing pearls that simplify complex decisions and help you match the right medication to the right patient. We'll cover acute mania versus bipolar depression, maintenance therapy, medication receptor profiles, metabolic considerations, weight gain, sedation, akathisia, prolactin elevation, movement disorders, and how patient-specific goals should influence every prescribing decision. You'll also learn why treating the episode in front of you isn't enough—and why thinking one step ahead can dramatically improve long-term outcomes for your patients. Whether you're a PMHNP student, psychiatry resident, physician assistant, psychiatric nurse practitioner, or practicing clinician, this episode will help you prescribe with greater confidence, stronger clinical reasoning, and a deeper understanding of why one antipsychotic may be a much better choice than another. 32 How I Choose Antipsychotics in Real Clinical Practice: 4 Pearls That Will Transform Your Bipolar Prescribing Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
  • S1 · E32
    July 29 · 19 min

    The 6 Reasons Experienced Clinicians Reach for Wellbutrin First

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep The 6 Reasons Experienced Clinicians Reach for Wellbutrin First | Pearls & Prep Thinking about prescribing Wellbutrin (bupropion)? In this episode of Pearls & Prep, NPZ sits down for one of his favorite types of conversations—the kind that goes beyond randomized controlled trials and dives into how medications actually perform in everyday psychiatric practice. Drawing from years of clinical experience and thousands of psychiatric evaluations, NPZ shares the practical decision-making process behind one of psychiatry's most unique antidepressants. You'll learn the six clinical reasons Wellbutrin frequently earns a place in NPZ's treatment toolbox, including why it stands apart from SSRIs like Prozac, Zoloft, and Lexapro. We discuss why Wellbutrin is often considered for patients concerned about weight gain or sexual dysfunction, why its dopaminergic and noradrenergic effects can be particularly helpful for patients struggling with fatigue, brain fog, low motivation, and anhedonia, and why many clinicians describe it as a medication that helps patients "get moving again." This episode also explores situations where Wellbutrin can serve multiple purposes, including patients with depression who also have symptoms suggestive of ADHD, as well as its FDA-approved role in smoking cessation as Zyban. NPZ discusses where Wellbutrin fits into treatment algorithms, when it works well as an augmentation strategy alongside SSRIs, and why understanding neurotransmitters is only one piece of becoming a confident psychiatric clinician. Of course, no medication is perfect. We also cover important contraindications—including seizure disorders, eating disorders, CYP2D6 interactions, and common reasons patients discontinue Wellbutrin, such as increased anxiety or irritability. Most importantly, you'll learn how experienced clinicians think through these tradeoffs rather than simply memorizing medication facts. Whether you're a PMHNP student, psychiatric nurse practitioner, psychiatry resident, physician assistant, psychiatrist, or another mental health professional looking to sharpen your psychopharmacology skills, this episode is packed with practical clinical pearls you can immediately apply in practice. Topics Covered: Wellbutrin (Bupropion) Clinical Pearls Wellbutrin vs SSRIs Prozac vs Wellbutrin Zoloft vs Wellbutrin Lexapro vs Wellbutrin Depression with fatigue and low motivation Dopamine vs serotonin ADHD and Wellbutrin Smoking cessation (Zyban) Antidepressant sexual dysfunction Weight gain and antidepressants CYP2D6 drug interactions PMHNP education Psychopharmacology Psychiatric medication management Clinical reasoning for new psychiatric providers 🎧 If you're looking for practical psychopharmacology, memorable clinical pearls, and the kind of mentorship conversations that bridge the gap between textbooks and real-world psychiatry, you're in the right place. 32 The 6 Reasons Experienced Clinicians Reach for Wellbutrin First Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
  • S1 · E26
    July 28 · 18 min

    Antipsychotic Switching: Key Concepts and Clinical Considerations

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Be the second on Patreon: 👉 https://www.patreon.com/PearlsandPrep The primary focus of this discourse is the critical examination of antipsychotic medication switching, emphasizing the imperative considerations that must govern such transitions. We delve into the rationale behind a patient's desire to switch their antipsychotic, particularly addressing issues of efficacy and adverse side effects. It is paramount for clinicians to possess a comprehensive understanding of receptor dynamics and affinities, as these factors significantly influence the therapeutic decision-making process. Additionally, we illustrate the potential consequences of abrupt medication changes through a case study, which underscores the risks associated with inadequate cross-titration and the importance of maintaining an effective dopamine blockade. Throughout this episode, we aim to equip listeners with the knowledge necessary to navigate the complexities of antipsychotic management with confidence and precision. 26 Antipsychotic Switching: Key Concepts and Clinical Considerations Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink JOIN! The discourse presented in the podcast meticulously delves into the intricate process of switching antipsychotic medications, a subject of paramount importance in psychiatric practice. The speaker elucidates the various rationales for transitioning patients from one antipsychotic to another, highlighting factors such as diminished efficacy or intolerable side effects, which may compel both clinicians and patients to consider alternative therapeutic options. The discussion further emphasizes the necessity of understanding the pharmacodynamics of different antipsychotics, particularly the significance of receptor affinity, which varies among medications within the second-generation antipsychotic category. This knowledge is deemed essential for making informed clinical decisions that prioritize patient safety and therapeutic efficacy. An illustrative case study involving a hypothetical patient, Lydia, provides a practical framework for understanding the complexities involved in medication switching. Lydia's case, characterized by a history of schizoaffective disorder and significant psychiatric episodes, serves to exemplify the high stakes associated with altering antipsychotic regimens, particularly when a patient has maintained relative stability on a specific medication for an extended period. The speaker articulates the critical importance of carefully assessing a patient’s psychiatric history and the potential ramifications of abrupt medication discontinuation, particularly regarding the risk of rebound psychosis and the necessity for adequate dopamine blockade. The conversation ultimately underscores the importance of a nuanced approach to medication management, advocating for a thorough consideration of both pharmacological properties and patient-specific factors before implementing treatment changes. Takeaways: The process of switching antipsychotics requires a thorough understanding of receptor affinities and potential side effects. It is essential to consider the patient's psychiatric history and the stakes involved in the switch. Directly switching from one antipsychotic to another without a careful plan can lead to destabilization in the patient. Understanding the pharmacodynamics of medications like Risperdal and Seroquel is crucial for effective treatment management. The timing of medication transitions and the maintenance of effective dopamine blockade are critical aspects in managing patient care. Each antipsychotic has unique properties and must be evaluated based on individual patient needs and histories. Companies mentioned in this episode: Risperdal Seroquel Abilify Geodon This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
    • Chapters
  • S1 · E32
    July 26 · 22 min

    The Grocery Store Trick That Will Change How You Understand Every Psychiatric Medication (Stop Memorizing CYP Enzymes Forever)

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep The Grocery Store Trick That Will Change How You Understand Every Psychiatric Medication (Stop Memorizing CYP Enzymes Forever) Every psychiatric medication can be understood by answering just two questions—and once you see them through the lens of a grocery store, you'll never look at psychopharmacology the same way again. In this episode of Pearls & Prep, I introduce what I believe is the single most useful mental model for understanding CYP450 enzymes, pharmacokinetics, pharmacogenomics, and drug interactions without memorizing endless charts. Instead of rote memorization, you'll learn how to think like a clinician. Using sertraline (Zoloft), escitalopram (Lexapro), and fluoxetine (Prozac) as examples, you'll finally understand: Why some medications have multiple "checkout lanes" while others depend on just one. Why Prozac causes so many clinically significant drug interactions. Why Lexapro is incredibly "clean" for other medications—but can become problematic in CYP2C19 poor metabolizers. Why Zoloft is often one of the most flexible and forgiving SSRIs in clinical practice. How to separate "How is MY drug metabolized?" from "Does MY drug interfere with OTHER drugs?"—two questions that every prescriber should ask before writing a prescription. Whether you're a PMHNP student, psychiatry resident, PA, physician, pharmacist, or practicing psychiatric clinician, this episode will give you a visual framework that makes antidepressant prescribing easier, safer, and far more intuitive. If you've ever felt overwhelmed by CYP enzymes, SSRI drug interactions, pharmacokinetics, or pharmacogenomics, this episode is for you. Keywords: psychopharmacology, psychiatric medications, CYP450 enzymes, CYP2D6, CYP2C19, SSRI drug interactions, Prozac, fluoxetine, Lexapro, escitalopram, Zoloft, sertraline, antidepressants, pharmacokinetics, pharmacogenomics, medication metabolism, psychiatry, PMHNP, psychiatric nurse practitioner, medication interactions. 32 The Grocery Store Trick That Will Change How You Understand Every Psychiatric Medication (Stop Memorizing CYP Enzymes Forever) Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
  • S1 · E32
    July 24 · 25 min

    The Bipolar Medication Mistake That Keeps Patients Relapsing

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep The Polarity Index may be one of the most underutilized concepts in bipolar disorder—and once you understand it, choosing maintenance medications becomes dramatically easier. In this episode, I break down the Polarity Index into plain language and show you how to stop memorizing drug lists and start thinking like an expert clinician. You'll learn why acute treatment and maintenance treatment are not the same decision, how to identify a patient's predominant pole (mania vs. depression), and how that single insight can transform your medication selection. Through realistic mock patient cases, we'll walk through when to choose lamotrigine, lithium, quetiapine, aripiprazole, lurasidone, cariprazine, and Symbyax, while tying every decision back to receptor pharmacology and long-term relapse prevention. In this episode you'll learn: What the Polarity Index actually measures The difference between acute stabilization and maintenance treatment How to identify a patient's predominant pole Why treating today's episode isn't always the same as preventing tomorrow's relapse When to choose lamotrigine, lithium, quetiapine, aripiprazole, lurasidone or cariprazine. The receptor mechanisms that explain why these medications work Clinical pearls that can immediately improve your bipolar prescribing Whether you're a PMHNP student, psychiatry resident, psychiatric nurse practitioner, physician assistant, psychiatrist, or anyone looking to master psychopharmacology, this episode provides a practical framework you'll use every time you treat bipolar disorder. OG article on polarity index: https://www.sciencedirect.com/science/article/abs/pii/S0924977X11002616?via%3Dihub This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
  • S1 · E32
    July 23 · 18 min

    Why Abilify Isn't an Antidepressant (But Helps with Depression)

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep Why is Abilify used for major depressive disorder (MDD) augmentation if it isn't actually an antidepressant? This is one of the most confusing concepts for psychiatric nurse practitioner students, physician assistants, psychiatry residents, medical students, and even new clinicians learning psychopharmacology. In this Off the PHARM episode, we break down Abilify (aripiprazole) augmentation using a memorable visual analogy you'll never forget. Imagine major depression as a clogged toilet. The SSRI is the plumber—it comes in to fix the primary problem by increasing serotonin and treating depressive symptoms. But while doing its job, the plumber accidentally creates some collateral damage by bumping into other serotonin receptors, contributing to common SSRI side effects such as sexual dysfunction, nausea, gastrointestinal upset, appetite changes, weight gain, activation, and early anxiety. That's where Abilify comes in. Abilify doesn't "unclog the toilet" by itself. It isn't considered a traditional antidepressant for monotherapy in major depressive disorder. Instead, it serves as an augmentation strategy, helping optimize the overall system and improve outcomes when an SSRI alone isn't enough. In this episode you'll learn: • Why Abilify is FDA-approved as an adjunctive treatment for major depressive disorder. • Why augmentation is different from antidepressant monotherapy. • How SSRIs interact with multiple serotonin receptor subtypes. • Why serotonin receptor activity contributes to both therapeutic benefits and adverse effects. • A simple visual framework for remembering psychopharmacology during clinical practice and PMHNP board preparation. • Practical prescribing pearls you can immediately apply in outpatient psychiatry. Whether you're studying for the PMHNP boards, preparing for psychiatry exams, or simply want psychopharmacology explained in a way that finally sticks, this episode turns a difficult concept into an unforgettable visual story. Keywords: Abilify, aripiprazole, SSRI, antidepressants, augmentation, adjunctive therapy, major depressive disorder, MDD, psychopharmacology, serotonin receptors, 5-HT2A, 5-HT2C, 5-HT3, 5-HT1A, psychiatric nurse practitioner, PMHNP, psychiatry boards, psych NP, depression treatment, visual learning, psychiatry education, dopamine, serotonin, medication side effects, board review. 32 Why Abilify Isn't an Antidepressant (But Helps with Depression) Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
  • S1 · E32
    July 22 · 15 min

    Why Your Bipolar Patient Keeps Relapsing: The Polarity Index

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep In this episode of Pearls & Prep, we tackle one of the highest-yield—but least discussed—concepts in bipolar disorder: the Polarity Index. If you've ever wondered why one maintenance medication seems to fit one bipolar patient perfectly while another falls flat, this episode gives you a practical framework you'll use for years. We'll start by breaking down what the Polarity Index is, where it came from, and why researchers developed it in the first place. Then we'll introduce the concept of predominant polarity—a simple way to identify whether a patient's illness has historically been driven more by manic episodes or depressive episodes. From there, I teach you the hard-and-fast rule that makes remembering this concept incredibly easy: high Polarity Index = better at preventing mania; low Polarity Index = better at preventing depression; values near 1 = balanced protection. Once you understand that rule, choosing and remembering maintenance medications becomes dramatically simpler. We'll also review the polarity indices of several commonly used bipolar maintenance medications, discuss how to think about them clinically, highlight a few memorable patient examples, and finish with practical board pearls you can immediately apply in both exam questions and real-world practice. Whether you're studying for the PMHNP boards, preparing for rotations, or simply want a cleaner mental framework for bipolar maintenance treatment, this episode will leave you with one of the most practical prescribing pearls in psychiatry. Topics covered: Bipolar Disorder • Bipolar I Disorder • Polarity Index • Predominant Polarity • Bipolar Maintenance Treatment • Mood Stabilizers • Aripiprazole • Lamotrigine • Lithium • Quetiapine • PMHNP Boards • Psychiatry Education • Psychopharmacology • Clinical Pearls • Psychiatric Nurse Practitioner 32 Why Your Bipolar Patient Keeps Relapsing: The Polarity Index Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
  • S1 · E27
    July 21 · 20 min

    Naltrexone: Your New Bestie in Alcohol Management. Using the Sinclair Method to Up Your Game In Practice.

    There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Be the second on Patreon: 👉 https://www.patreon.com/PearlsandPrep Today, we're diving into the fascinating world of the Sinclair Method and how it can totally change the game for folks dealing with alcohol use issues. It's all about understanding the *why* behind drinking, not just the *how much*. We’ve got a mock patient named Marcus, who finds himself reaching for those brews not to escape but to enjoy the buzz. By the end of this episode, you're gonna feel like a pro, armed with the knowledge to help your patients better. So, grab your surfboard and ride the wave of information as we explore how this method can help folks manage their drinking while still having a good time! 27 Naltrexone: Your New Bestie in Alcohol Management. Using the Sinclair Method to Up Your Game In Practice. Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Takeaways: This episode is all about giving you the lowdown on the Sinclair method for treating alcohol use disorder, which is pretty neat, right? Understanding the difference between drinking for pleasure and drinking to cope can totally change how we approach treatment for our patients. The Sinclair method involves taking naltrexone before drinking, which helps reduce cravings and makes drinking less rewarding—how cool is that? Recognizing the various drinking phenotypes is key to tailoring treatment; not all drinkers are created equal, my friends! Naltrexone can be a game-changer for those who drink mainly for pleasure, giving them a major edge in cutting down on heavy drinking. Don't underestimate the importance of understanding why someone drinks; context is everything in guiding effective treatment strategies. Companies mentioned in this episode: Prozac lithium AA naltrexone Sinclair method predict trial camper state va dod apa aaf aafp This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

    • Transcript
    • Chapters
Showing 1–20 of 21 episodes